{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:22:30Z","timestamp":1791051750767,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s12149-007-0096-x","type":"journal-article","created":{"date-parts":[[2008,5,23]],"date-time":"2008-05-23T16:24:12Z","timestamp":1211559852000},"page":"231-235","source":"Crossref","is-referenced-by-count":64,"title":["Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma"],"prefix":"10.1007","volume":"22","author":[{"given":"Ichiei","family":"Kuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Imabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,23]]},"reference":[{"key":"96_CR1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiology.186.3.8430179","volume":"186","author":"B.L. Shulkin","year":"1993","unstructured":"Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 1993;186:711\u2013715.","journal-title":"Radiology"},{"key":"96_CR2","first-page":"782","volume":"92","author":"S. Maurea","year":"1996","unstructured":"Maurea S, Mainolfi C, Wang H, Varrella P, Panico MR, Klain M, et al. Positron emission tomography (PET) with F-18-fluorodeoxyglucose in the study of adrenal masses: comparison of benign and malignant lesions. Radiol Med (Torino) 1996;92:782\u2013787.","journal-title":"Radiol Med (Torino)"},{"key":"96_CR3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00259-002-0902-6","volume":"29","author":"T.F. Hany","year":"2002","unstructured":"Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 2002;29:1393\u20131398.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"96_CR4","first-page":"170","volume":"44","author":"C. Cohade","year":"2003","unstructured":"Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat (\u201cUSA-Fat\u201d): description on 18F-FDG PET\/CT. J Nucl Med 2003;44:170\u2013176.","journal-title":"J Nucl Med"},{"key":"96_CR5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-2004-830407","volume":"112","author":"K. Fukuchi","year":"2004","unstructured":"Fukuchi K, Tatsumi M, Ishida Y, Oku N, Hatazawa J, Wahl RL. Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma. Exp Clin Endocrinol Diabetes 2004;112:601\u2013603.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"96_CR6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1148\/107.2.279","volume":"107","author":"J.T. English","year":"1973","unstructured":"English JT, Patel SK, Flanagan MJ. Association of pheochromocytomas with brown fat tumors. Radiology 1973;107:279\u2013281.","journal-title":"Radiology"},{"key":"96_CR7","first-page":"219","volume":"10","author":"M.E. Lean","year":"1986","unstructured":"Lean ME, James WP, Jennings G, Trayhurn P. Brown adipose tissue in patients with phaeochromocytoma. Int J Obes 1986;10:219\u2013227.","journal-title":"Int J Obes"},{"key":"96_CR8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2214\/ajr.184.3.01840860","volume":"184","author":"K.M. Elsayes","year":"2005","unstructured":"Elsayes KM, Narra VR, Leyendecker JR, Francis IR, Lewis JS Jr, Brown JJ. MRI of adrenal and extraadrenal pheochromocytoma. AJR Am J Roentgenol 2005;184:860\u2013867.","journal-title":"AJR Am J Roentgenol"},{"key":"96_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2265.1997.d01-1738.x","volume":"46","author":"D. Kopf","year":"1997","unstructured":"Kopf D, Bockisch A, Steinert H, Hahn K, Beyer J, Neumann HP, et al. Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma. Clin Endocrinol (Oxf) 1997;46:39\u201344.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"96_CR10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1210\/en.2003-0857","volume":"145","author":"E. Chernogubova","year":"2004","unstructured":"Chernogubova E, Cannon B, Bengtsson T. Norepinephrine increases glucose transport in brown adipocytes via beta 3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology 2004;145:269\u2013280.","journal-title":"Endocrinology"},{"key":"96_CR11","first-page":"1189","volume":"45","author":"M. Tatsumi","year":"2004","unstructured":"Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL. Intense 18F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 2004;45:1189\u20131193.","journal-title":"J Nucl Med"},{"key":"96_CR12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00259-006-0318-9","volume":"34","author":"V. Soderlund","year":"2007","unstructured":"Soderlund V, Larsson SA, Jacobsson H. Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur J Nucl Med Mol Imaging 2007;34:1018\u20131022.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"96_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1563-2571.2003.03002.x","volume":"30","author":"C. Menzel","year":"2003","unstructured":"Menzel C, Graichen S, Berner U, Risse JH, Diehl M, Dobert N, et al. Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET. Acta Med Austriaca 2003;30:37\u201340.","journal-title":"Acta Med Austriaca"},{"key":"96_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.rlu.0000170060.52675.14","volume":"30","author":"S. Ezuddin","year":"2005","unstructured":"Ezuddin S, Fragkaki C. MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy. Clin Nucl Med 2005;30:579\u2013581.","journal-title":"Clin Nucl Med"},{"key":"96_CR15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1507\/endocrj.48.151","volume":"48","author":"B. Glodny","year":"2001","unstructured":"Glodny B, Winde G, Herwig R, Meier A, Kuhle C, Cromme S, et al. Clinical differences between benign and malignant pheochromocytomas. Endocr J 2001;48:151\u2013159.","journal-title":"Endocr J"},{"key":"96_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1385\/EP:13:2:149","volume":"13","author":"N. Kumaki","year":"2002","unstructured":"Kumaki N, Kajiwara H, Kameyama K, DeLellis RA, Asa SL, Osamura RY, et al. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol 2002;13:149\u2013156.","journal-title":"Endocr Pathol"},{"issue":"Suppl1","key":"96_CR17","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1148\/rg.24si045514","volume":"24","author":"K.M. Elsayes","year":"2004","unstructured":"Elsayes KM, Mukundan G, Narra VR, Lewis JS Jr, Shirkhoda A, Farooki A, et al. Adrenal masses: MR imaging features with pathologic correlation. Radiographics 2004;24Suppl 1:S73\u2013S86.","journal-title":"Radiographics"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-007-0096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-007-0096-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-007-0096-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:41:46Z","timestamp":1559450506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-007-0096-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s12149-007-0096-x","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}